Week-to-week within-subject and between-subject biological variation of copeptin
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Clinical chemistry and laboratory medicine - 62(2024), 2 vom: 26. Jan., Seite e29-e33 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Guldhaug, Nora Alicia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analytical performance specifications |
|---|
| Anmerkungen: |
Date Completed 18.12.2023 Date Revised 09.03.2024 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.1515/cclm-2023-0673 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36033024X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36033024X | ||
| 003 | DE-627 | ||
| 005 | 20240309231906.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/cclm-2023-0673 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1321.xml |
| 035 | |a (DE-627)NLM36033024X | ||
| 035 | |a (NLM)37533276 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Guldhaug, Nora Alicia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Week-to-week within-subject and between-subject biological variation of copeptin |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.12.2023 | ||
| 500 | |a Date Revised 09.03.2024 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a analytical performance specifications | |
| 650 | 4 | |a anti-diuretic hormone | |
| 650 | 4 | |a biological variation | |
| 650 | 4 | |a index of individuality | |
| 650 | 4 | |a reference change values | |
| 650 | 7 | |a copeptins |2 NLM | |
| 700 | 1 | |a Røys, Eirik Åsen |e verfasserin |4 aut | |
| 700 | 1 | |a Viste, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Thorsby, Per Medbøe |e verfasserin |4 aut | |
| 700 | 1 | |a Sylte, Marit Sverresdotter |e verfasserin |4 aut | |
| 700 | 1 | |a Torsvik, Janniche |e verfasserin |4 aut | |
| 700 | 1 | |a Strand, Heidi |e verfasserin |4 aut | |
| 700 | 1 | |a Alaour, Bashir |e verfasserin |4 aut | |
| 700 | 1 | |a Marber, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Omland, Torbjørn |e verfasserin |4 aut | |
| 700 | 1 | |a Aakre, Kristin Moberg |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d 1998 |g 62(2024), 2 vom: 26. Jan., Seite e29-e33 |w (DE-627)NLM095304118 |x 1437-4331 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2024 |g number:2 |g day:26 |g month:01 |g pages:e29-e33 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1515/cclm-2023-0673 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2024 |e 2 |b 26 |c 01 |h e29-e33 | ||